We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
-3.28%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$15.4B
AUM Growth
+$3.25B
(+27%)
Cap. Flow
+$3.84B
Cap. Flow
% of AUM
24.9%
Top 10 Holdings %
Top 10 Hldgs %
24.83%
Holding
2,819
New
321
Increased
2,347
Reduced
46
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$246M |
| 2 |
Microsoft
MSFT
|
+$216M |
| 3 |
Amazon
AMZN
|
+$130M |
| 4 |
Tesla
TSLA
|
+$79.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$73.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$49.3M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$11.7M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$11.6M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.56M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$5.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 12.21% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Mercantile Bank Corp
MBWM
$1.06B
| $297K | ﹤0.01% |
8,397
+3,047
| +57% | +$114K |
|
|
NEUE
2102
DELISTED
NeueHealth
NEUE
| $297K | ﹤0.01% |
+1,925
| New | +$428K |
|
|
STEL
2103
DELISTED
Stellar Bancorp
STEL
| $297K | ﹤0.01% |
9,567
+3,396
| +55% | +$103K |
|
|
DHIL
2104
DELISTED
Diamond Hill
DHIL
| $296K | ﹤0.01% |
1,582
+525
| +50% | +$97.5K |
|
2105
MiMedx Group
MDXG
$612M
| $296K | ﹤0.01% |
62,811
+22,593
| +56% | +$110K |
|
2106
Douglas Elliman
DOUG
$183M
| $295K | ﹤0.01% |
42,438
+18,597
| +78% | +$141K |
|
|
ALBO
2107
DELISTED
Albireo Pharma Inc
ALBO
| $294K | ﹤0.01% |
9,864
+3,466
| +54% | +$101K |
|
2108
Select Water Solutions
WTTR
$2.63B
| $294K | ﹤0.01% |
34,292
+12,227
| +55% | +$95.3K |
|
2109
MacroGenics
MGNX
$259M
| $294K | ﹤0.01% |
33,326
+12,267
| +58% | +$135K |
|
2110
Ally Financial
ALLY
$13.6B
| $294K | ﹤0.01% |
+6,752
| New | +$319K |
|
2111
OraSure Technologies
OSUR
$277M
| $293K | ﹤0.01% |
43,288
+14,653
| +51% | +$117K |
|
|
THR
2112
DELISTED
Thermon Group Holdings
THR
| $292K | ﹤0.01% |
18,025
+6,427
| +55% | +$112K |
|
2113
Vertiv
VRT
$111B
| $291K | ﹤0.01% |
+20,792
| New | +$370K |
|
|
ECOM
2114
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $291K | ﹤0.01% |
17,557
+6,576
| +60% | +$125K |
|
2115
Bank of Marin Bancorp
BMRC
$462M
| $291K | ﹤0.01% |
8,295
+3,103
| +60% | +$113K |
|
|
ALX
2116
Alexander's
ALX
$1.4B
| $291K | ﹤0.01% |
1,134
+375
| +49% | +$96.6K |
|
|
MAGN
2117
Magnera Corp
MAGN
$433M
| $289K | ﹤0.01% |
1,795
+648
| +56% | +$128K |
|
2118
Farmers National Banc Corp
FMNB
$970M
| $289K | ﹤0.01% |
16,920
+5,913
| +54% | +$105K |
|
|
WW
2119
DELISTED
WW International
WW
| $289K | ﹤0.01% |
28,205
+9,291
| +49% | +$109K |
|
|
HIBB
2120
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $288K | ﹤0.01% |
6,500
+876
| +16% | +$47.4K |
|
2121
The GEO Group
GEO
$4B
| $288K | ﹤0.01% |
43,546
+2,759
| +7% | +$18.1K |
|
|
LONA
2122
LeonaBio Inc
LONA
$73.9M
| $287K | ﹤0.01% |
2,123
+753
| +55% | +$79.4K |
|
2123
Absci
ABSI
$1.62B
| $285K | ﹤0.01% |
+33,791
| New | +$265K |
|
2124
Caribou Biosciences
CRBU
$160M
| $285K | ﹤0.01% |
31,003
+23,472
| +312% | +$247K |
|
2125
The Joint Corp
JYNT
$119M
| $285K | ﹤0.01% |
8,041
+2,953
| +58% | +$137K |
|
Similar funds
PCM
HHII
EIM
P
BPA
NAM
MIC
MetLife Investment Management's Q1 2022 Portfolio in Review
As of Q1 2022, MetLife Investment Management held 2,819 positions worth $15.4B, up 27% from $12.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
MetLife Investment Management deployed $3.84B of net new capital in Q1 2022, opening 321 new positions and adding to 2,347 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $49.3M trimmed.
- MetLife Investment Management's largest Q1 2022 buy was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
- MetLife Investment Management added most to Apple in Q1 2022, an estimated $246M increase.
- MetLife Investment Management's biggest Q1 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $49.3M.
- MetLife Investment Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $11.7M.
- MetLife Investment Management's ten largest holdings make up 25% of its $15.4B portfolio in Q1 2022.
- MetLife Investment Management opened 321 new positions and closed 92 in Q1 2022.
- MetLife Investment Management's portfolio value rose 27% quarter-over-quarter to $15.4B.
Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.